NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Rejuvenate Bio

Rejuvenate Bio

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://rejuvenatebio.com/

Last Round

Financing

Jun 8, 2026

Total Funding Raised

$14M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Rejuvenate Bio is a biotechnology company that develops a biotechnology platform designed to increase healthspan and extend lifespan through novel gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

gene therapylongevity biotechage-related diseasesepigenetic reprogramminganimal healthAAV gene therapyveterinary gene therapycellular rejuvenationdual-market strategytranslational medicineAAV vectorscanine mitral valve diseaseheart failure therapymetabolic disease therapyanti-aging therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rejuvenate Bio Comparables

Compare Rejuvenate Bio with similar companies based on industry and business-model similarity.

Rejuvenate Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genflow Biosciences
84%
Turn Biotechnologies
80%
Life Biosciences
79%

Rejuvenate Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
FinancingJun 8, 2026
CrowdfundingApr 27, 2026
GrantJul 1, 2024
Series AApr 19, 2021

Key People

Founding team and executive leadership

Daniel Oliver

CEO And Founder

Founding Team

Rejuvenate Bio Investors

Notable investors and investment history

Rejuvenate Bio investors
InvestorRounds
Kendall Capital PartnersFinancing, Series A
Connecticut InnovationsFinancing
Digitalis VenturesFinancing, Series A
California Institute for Regenerative MedicineGrant
KdT VenturesSeries A
VCapitalSeries A, Financing

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 8, 2026

    $6M raised with VCapital leading the round.

  • Apr 27, 2026

    Raised funds through Wefunder platform.

Rejuvenate Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rejuvenate Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rejuvenate Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range16
Year Founded2017
Last FundingJun 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.